PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 37 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $250,000 | -5.7% | 250,000 | -5.7% | 0.00% | – |
| Q2 2017 | $265,000 | -52.1% | 265,000 | -52.7% | 0.00% | – |
| Q1 2017 | $553,000 | +1.3% | 560,000 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $546,000 | -5.5% | 560,000 | -5.9% | 0.00% | 0.0% |
| Q3 2016 | $578,000 | -27.4% | 595,000 | +549.2% | 0.00% | 0.0% |
| Q2 2016 | $796,000 | +11.3% | 91,648 | -88.4% | 0.00% | 0.0% |
| Q1 2016 | $715,000 | +28.1% | 792,000 | +13.6% | 0.00% | 0.0% |
| Q4 2015 | $558,000 | -44.8% | 697,000 | -39.2% | 0.00% | 0.0% |
| Q3 2015 | $1,011,000 | -26.3% | 1,147,000 | -20.7% | 0.00% | 0.0% |
| Q2 2015 | $1,372,000 | +20.4% | 1,447,000 | +21.4% | 0.00% | 0.0% |
| Q1 2015 | $1,140,000 | +138.5% | 1,192,000 | +138.4% | 0.00% | – |
| Q4 2014 | $478,000 | -1.8% | 500,000 | 0.0% | 0.00% | – |
| Q3 2014 | $487,000 | -21.2% | 500,000 | -7.2% | 0.00% | -100.0% |
| Q2 2014 | $618,000 | -46.6% | 539,000 | -51.0% | 0.00% | 0.0% |
| Q1 2014 | $1,158,000 | – | 1,100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|